Upcoming Events

Myeloma Cure Summit: Definitions, Metrics, and Milestones

Myeloma Cure Summit: Definitions, Metrics, and Milestones

February 20 - 21, 2026 - Virtual

A central goal for this meeting is to establish a working consensus on the definition of “cure” in myeloma with international thought leaders on myeloma. Dedicated sessions will evaluate key parameters including depth and durability of minimal residual disease (MRD) negativity, advanced imaging, mass spectrometry, immune reconstitution, time off therapy, restoration of normal function, and potential reversion to an MGUS-like state. These metrics will be discussed under the guidance of leading investigators and clinicians.

 

Preliminary Program

Educational Workshop in Belgrade, Serbia

Educational Workshop in Belgrade, Serbia

March 13 - 14, 2026 - Hyatt Regency Belgrade and on-demand

Join us for a dynamic educational workshop on the diagnosis, treatment, and monitoring of plasma cell malignancies, including current practices and opportunities for improvement. This workshop will include lectures plus roundtable discussions around hot and controversial topics, featuring point-counterpoint conversations between invited speakers and local hematologists based on both challenging questions and clinical cases.

 

Preliminary Program

7th Immune Effector Cell Therapies in Multiple Myeloma Workshop

7th Immune Effector Cell Therapies in Multiple Myeloma Workshop

March 27 - 28, 2026 - Boston Marriott Long Wharf, Boston, MA

IMS is pleased to announce that the 7th Annual Immune Effector Cell will take place from March 27-28, 2026 in Boston, MA.

4th Annual Workshop on Genomics

4th Annual Workshop on Genomics

July 10 - 11, 2026 - The Westin Warsaw, Warsaw, Poland

IMS is pleased to announce that the 4th Annual Workshop on Genomics will take place from July 10-11, 2026 in Warsaw, Poland.

More details will be available soon!

23rd Annual Meeting & Exposition

23rd Annual Meeting & Exposition

September 23 - 26, 2026 - Glasgow, Scotland

Mark your calendars for the 23rd IMS Annual Meeting in Glasgow, Scotland.

 

The International Myeloma Society Annual Meeting is the defining annual meeting in myeloma.

More details on the program, abstract submissions, registration and housing will be available soon.

Applications are now being accepted for the IMS Translational Research Award – Deadline January 30, 2026

Applications are now being accepted for the IMS Career Development Award – Deadline January 30, 2026

 

 

Meet the recipients of the IMS Translational Research Award!

Meet the recipients of the IMS Career Development Award!

About Our Publications

As a response to the current pandemic, the International Myeloma Society Executive Committee has developed the following Recommendations for the Management of Myeloma Patients During the COVID-19 Pandemic. These recommendations include directions for caring for newly diagnosed, elderly, relapsed/refractory and clinical trial patients. Please follow as appropriate for your practice and patient needs. The International Myeloma Society remains committed to keeping patients and physicians safe while providing care and treatment under these extraordinary circumstances.

See All Publications

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.

The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Login
See All of the Member Benefits
Become a Member Today

Stay updated on our Events

Ein Casino ohne Verifizierung auszahlen bietet einfache Transaktionen und Diskretion für jeden Spieler.